EMA Recommends Extension of Therapeutic Indications for Acalabrutinib By Ogkologos - June 18, 2025 786 0 Facebook Twitter Google+ Pinterest WhatsApp A new indication concerns the treatment of adult patients with previously untreated CLL in combination with venetoclax Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Divarasib in Combination with Cetuximab Demonstrates a Manageable Safety Profile and... December 20, 2023 Scottish Soccer Star Who Just Announced Breast Cancer Diagnosis Scores Goal,... December 21, 2020 News digest – targeted radiation beam, precision medicine and our early... October 17, 2020 Reunión anual de la American Society of Clinical Oncology de 2022:... June 4, 2022 Load more HOT NEWS Radiation Treatment Delivery Improved Using a Visualization of the Invisible Radiation... Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App Making a startup out of a scientist Thank you!
